SYMJEPI Trademark

Trademark Overview


On Friday, October 19, 2018, a trademark application was filed for SYMJEPI with the United States Patent and Trademark Office. The USPTO has given the SYMJEPI trademark a serial number of 88162331. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 13, 2026. This trademark is owned by Adamis Pharmaceuticals Corporation. The SYMJEPI trademark is filed in the Pharmaceutical Products category with the following description:

Injectable solution of epinephrine for treating allergic reactions; Prefilled syringe for injecting an epinephrine solution
symjepi

General Information


Serial Number88162331
Word MarkSYMJEPI
Filing DateFriday, October 19, 2018
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 13, 2026
Registration Number5853281
Registration DateTuesday, September 3, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2019

Trademark Statements


Goods and ServicesInjectable solution of epinephrine for treating allergic reactions; Prefilled syringe for injecting an epinephrine solution

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 13, 2026
Primary Code005
First Use Anywhere DateFriday, November 30, 2018
First Use In Commerce DateFriday, November 30, 2018

Trademark Owner History


Party NameDMK PHARMACEUTICALS CORPORATION
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92130
US

Party NameAdamis Pharmaceuticals Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
US

Party NameAdamis Pharmaceuticals Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
US

Party NameAdamis Pharmaceuticals Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
US

Trademark Events


Event DateEvent Description
Tuesday, October 23, 2018NEW APPLICATION ENTERED
Thursday, November 1, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 29, 2019ASSIGNED TO EXAMINER
Tuesday, January 29, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 12, 2019PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 26, 2019TEAS STATEMENT OF USE RECEIVED
Thursday, July 18, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 26, 2019USE AMENDMENT FILED
Thursday, July 18, 2019STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 1, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, August 2, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 3, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, May 16, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, September 3, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, March 13, 2026CANCELLED SEC. 8 (6-YR)